Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Clinical trial NCT06820957 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06820957
Sponsor: Children's Oncology Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

CIC-Rearranged Sarcoma Metastatic Ewing Sarcoma Metastatic High Grade Sarcoma Metastatic Undifferentiated Round Cell Sarcoma Metastatic Undifferentiated Sarcoma, Not Otherwise Specified Round Cell Sarcoma With EWSR1-non-ETS Fusion Sarcoma With BCOR Genetic Alterations

Start date: 2025-11-10
Primary completion: 2026-06-30
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.